172 related articles for article (PubMed ID: 3872844)
1. Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b.
Toews GB; Hart DA; Hansen EJ
Infect Immun; 1985 May; 48(2):343-9. PubMed ID: 3872844
[TBL] [Abstract][Full Text] [Related]
2. Effect of primary immunization on pulmonary clearance of nontypable Haemophilus influenzae.
McGehee JL; Radolf JD; Toews GB; Hansen EJ
Am J Respir Cell Mol Biol; 1989 Sep; 1(3):201-10. PubMed ID: 2624760
[TBL] [Abstract][Full Text] [Related]
3. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model.
Kyd JM; Dunkley ML; Cripps AW
Infect Immun; 1995 Aug; 63(8):2931-40. PubMed ID: 7622215
[TBL] [Abstract][Full Text] [Related]
4. Immune enhancement of pulmonary clearance of nontypable Haemophilus influenzae.
Hansen EJ; Hart DA; McGehee JL; Toews GB
Infect Immun; 1988 Jan; 56(1):182-90. PubMed ID: 3257203
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b.
Schreiber JR; Barrus V; Cates KL; Siber GR
J Infect Dis; 1986 Jan; 153(1):8-16. PubMed ID: 3484506
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of the immunological response in the clearance of non-typeable Haemophilus influenzae from the lung.
Foxwell AR; Kyd JM; Cripps AW
Immunol Cell Biol; 1998 Aug; 76(4):323-31. PubMed ID: 9723773
[TBL] [Abstract][Full Text] [Related]
7. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
Barbour ML; Booy R; Crook DW; Griffiths H; Chapel HM; Moxon ER; Mayon-White D
Pediatr Infect Dis J; 1993 Jun; 12(6):478-84. PubMed ID: 8345980
[TBL] [Abstract][Full Text] [Related]
8. Coprecipitation of lipopolysaccharide and the 39,000-molecular-weight major outer membrane protein of Haemophilus influenzae type b by lipopolysaccharide-directed monoclonal antibody.
Gulig PA; Hansen EJ
Infect Immun; 1985 Sep; 49(3):819-27. PubMed ID: 3875563
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model.
Kauppi-Korkeila M; van Alphen L; Madore D; Saarinen L; Käyhty H
J Infect Dis; 1996 Dec; 174(6):1337-40. PubMed ID: 8940229
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.
Hirano T; Hou Y; Jiao X; Gu XX
FEMS Immunol Med Microbiol; 2003 Jan; 35(1):1-10. PubMed ID: 12589951
[TBL] [Abstract][Full Text] [Related]
11. Effect of complement depletion on anticapsular-antibody-mediated immunity to experimental infection with Haemophilus influenzae type b.
Schreiber JR; Basker CJ; Siber GR
Infect Immun; 1987 Nov; 55(11):2830-3. PubMed ID: 3499398
[TBL] [Abstract][Full Text] [Related]
12. Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b.
Gulig PA; Patrick CC; Hermanstorfer L; McCracken GH; Hansen EJ
Infect Immun; 1987 Mar; 55(3):513-20. PubMed ID: 2434425
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary clearance of encapsulated and unencapsulated Haemophilus influenzae strains.
Toews GB; Viroslav S; Hart DA; Hansen EJ
Infect Immun; 1984 Aug; 45(2):437-42. PubMed ID: 6611311
[TBL] [Abstract][Full Text] [Related]
14. Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin.
Santosham M; Reid R; Ambrosino DM; Wolff MC; Almeido-Hill J; Priehs C; Aspery KM; Garrett S; Croll L; Foster S
N Engl J Med; 1987 Oct; 317(15):923-9. PubMed ID: 2442610
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a monoclonal antibody to the capsule of Haemophilus influenzae type b, generated by in vitro immunization.
Bunse R; Heinz HP
J Immunol Methods; 1994 Dec; 177(1-2):89-99. PubMed ID: 7822841
[TBL] [Abstract][Full Text] [Related]
16. A rapid and sensitive chemiluminescence assay for evaluation of functional opsonic activity of Haemophilus influenzae type b-specific antibodies.
Ojo-Amaize EA; Church JA; Barka NE; Agopian MS; Peter JB
Clin Diagn Lab Immunol; 1995 May; 2(3):286-90. PubMed ID: 7664173
[TBL] [Abstract][Full Text] [Related]
17. An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide.
Lucas AH; Langley RJ; Granoff DM; Nahm MH; Kitamura MY; Scott MG
J Clin Invest; 1991 Dec; 88(6):1811-8. PubMed ID: 1752943
[TBL] [Abstract][Full Text] [Related]
18. EF-Tu From Non-typeable
Thofte O; Su YC; Brant M; Littorin N; Duell BL; Alvarado V; Jalalvand F; Riesbeck K
Front Immunol; 2018; 9():2910. PubMed ID: 30619274
[TBL] [Abstract][Full Text] [Related]
19. PHiD-CV induces anti-Protein D antibodies but does not augment pulmonary clearance of nontypeable Haemophilus influenzae in mice.
Siggins MK; Gill SK; Langford PR; Li Y; Ladhani SN; Tregoning JS
Vaccine; 2015 Sep; 33(38):4954-61. PubMed ID: 26212006
[TBL] [Abstract][Full Text] [Related]
20. Protection against non-typable Haemophilus influenzae following sensitization of gut associated lymphoid tissue: role of specific antibody and phagocytes.
Wallace FJ; Witt CS; Clancy RL; Cripps AW
Immunol Cell Biol; 1995 Jun; 73(3):258-65. PubMed ID: 7590900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
